Measles virus vaccine live attenuated

Star1

DB10315ApprovedInvestigationalVaccinesLive Attenuated Measles Virus Vaccine

Measles virus vaccine live attenuated is a vaccine used to prevent Measles.

Primary indication: Measles virus vaccine is used to prevent measles in combination with other virus vaccines, such as the rubella and Mumps virus vaccine.Curator reviewed · 2 structured indications
First approval: Canada, 2007 · United States, 1971 · European Union, 2021
Also known as: Live attenuated measles virus (Schwartz strain) · Measles vaccine (live) · Measles virus live antigen · Measles virus vaccine live · Measles Virus Vaccine Live, Enders' attenuated Edmonston strain
Brand names: M-M-R II
M-M-RVaxPro
Proquad

Resolves to

Compound

UNIIMFZ8I7277D

Clinical / RWD

RxNorm804179

What you can answer from here — as of May 03, 2025

290Drug interactionsStructured to mechanism, not free text

69Clinical trialsPhase, status and sponsor resolved per trial

2Structured indicationsCondition, population, route and combination as fields, not prose

3ContraindicationsEach with its own population and attribute set

144Marketed productsAcross 10 countries and 21 labellers

2+ReferencesStructured and connected to the statements they support

Which other approved drugs treat the same conditions as Measles virus vaccine live attenuated, and which companies have late-stage candidates in those indications?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account